Key Takeaways

• IV hydration is the practice of medicine in California, regardless of marketing framing (wellness, recovery, longevity), location (brick-and-mortar, mobile, in-home), or payor mix (cash-pay, membership, superbill).
• The clinical entity must be a physician-owned professional corporation. An LLC cannot render medical services under Cal. Corp. Code § 17701.04(e).
• Non-licensee buyers acquire IV clinics through an asset purchase in which a licensed physician acquires clinical assets into a newly formed PC and the buyer’s MSO acquires non-clinical assets under a Management Services Agreement.
• Category-specific diligence issues include the good-faith exam workflow, standardized procedures for RN administration under 16 CCR § 1474, sterile-compounding and formulation sourcing (USP 797), mobile-operation compliance, controlled-substance registration where applicable, and marketing that overstates wellness outcomes.
• Paper medical director arrangements have been a frequent focus of Medical Board and BRN enforcement in the IV space. Diligence should surface whether the target has an actual clinical medical director or a paperwork one.

If you are a non-licensee buyer evaluating a California IV hydration business — a brick-and-mortar clinic, a mobile concierge operation, a wellness lounge, or a membership-based model, you are looking at a category where the marketing consistently says “wellness” and the legal classification consistently says “medical practice.” IV hydration is the administration of legend drugs (electrolyte fluids, added vitamins, glutathione, NAD+, sometimes anti-nausea or anti-inflammatory medications) directly into the bloodstream. It is the practice of medicine in California under B&P Code § 2052 and § 2400, regardless of whether the sessions are marketed as “wellness,” delivered at a client’s home, sold as a membership, or paid entirely in cash.

Non-licensee buyers acquire IV clinics through the friendly-PC + MSO structure, the same architecture used across California treatment businesses. What makes IV acquisitions distinct is a cluster of category-specific diligence issues — sterile compounding, mobile-operation risk, the good-faith exam workflow for medical-grade infusions, and the ambient enforcement focus the Medical Board and BRN have placed on IV hydration in 2024–2026. This post is the acquisition-side guide for IV; the general pillar covers the framework, and the remediation post covers what happens when a buyer inherits a non-compliant target.

Why IV Is a Medical Practice, Even When the Marketing Says Wellness

The threshold question comes up in almost every IV acquisition diligence call: “The seller says it’s just wellness. Do CPOM rules really apply?” The answer is yes, without ambiguity.

Three regulatory facts converge:

IV fluids and additives are legend drugs. Saline, lactated Ringer’s, dextrose solutions, and every common IV additive (B-complex, vitamin C, glutathione, NAD+, magnesium, calcium, zinc) are prescription drugs. Preparation and administration of prescription drugs requires a prescription from a licensed prescriber (physician, NP, or PA) based on a good-faith prior examination under B&P § 2242.

Venipuncture and IV administration are within the practice of medicine and delegated nursing scope. Establishing venous access and administering fluids and medications intravenously is not a retail service. It is a clinical procedure with clinical risks (extravasation, infection, adverse reactions, anaphylaxis) that requires clinical assessment and clinical oversight.

California’s CPOM doctrine applies functionally. B&P §§ 2052 and 2400 and the Moscone-Knox Professional Corporation Act reach the practice of medicine regardless of how the practice markets itself. “Wellness,” “recovery,” “longevity,” “hydration,” and “mobile concierge” are marketing labels. They do not remove the practice from the doctrine.

Common seller framings that do not change the analysis:

• “It’s just vitamins and fluids.” Vitamins and fluids delivered intravenously are legend drugs. The route of administration is what makes it medical.
• “It’s cash-pay so CPOM doesn’t apply.” Payor mix is not a CPOM defense.
• “We’re mobile, so it’s different.” There is no mobile carve-out from CPOM, the good-faith exam requirement, or standardized procedures.
• “The RN owns the business and runs everything.” RNs cannot own California medical corporations under Cal. Corp. Code § 13401.5(a). RNs can own MSOs that contract with physician-owned PCs, but they cannot own the clinical entity.
• “It runs like a retail store — patients pick a drip from a menu.” Menu-driven IV administration without individualized clinical assessment is one of the recurring issues Medical Board enforcement has targeted.

IV-Specific Diligence Issues for Non-Licensee Buyers

The general treatment-business diligence framework — CPOM structure, medical director role, direct patient billing, franchise-system MSA review, historical regulatory exposure, applies to IV. Seven category-specific issues warrant additional attention.

1. Physician-owned PC and physician role. Confirm the target has a physician-owned professional corporation formed under Cal. Corp. Code § 13401.5(a), and that the physician who owns it is actually functioning as the clinical medical director. Ask what the physician does — GFE conduct or supervision, standardized procedures development and approval, incident management, clinical protocol updates. Compensation should track services actually rendered. “A physician signs off on the protocols” without more is a paper arrangement.
2. Good-faith exam workflow. The 2026 California Medical Board and BRN posture treats standing orders and questionnaire-only intake as insufficient for IV therapy. Compliant IV clinics conduct a good-faith exam by a licensed prescriber (physician, NP, or PA) — in person or by synchronous video for mobile / telehealth-forward practices — before the first IV therapy session. The exam meets the standard of care under B&P § 2242 (history, examination appropriate to the service, review of contraindications) and results in a patient-specific order for the treatment plan. Ask to see the intake flow, sample charts, and the treatment order form. “The RN takes history and the medical director signs off later” is a defect.
3. Standardized procedures for RN administration. Where RNs administer IV therapy under physician (or NP) delegation, the delegation is governed by written standardized procedures under 16 CCR § 1474. The procedures manual has to be specific to the practice — actual formulations, actual equipment, actual staff — and has to be current, signed, and reviewed on a defined cadence. Generic templates from a formation service are a red flag. Missing manuals or manuals last signed on formation and never updated are red flags.
4. Sterile compounding and formulation sourcing. IV formulations range from simple saline to complex multi-additive “cocktails” that require sterile compounding. Compounding pharmacies serving IV clinics operate under USP 797 sterile compounding standards; some clinics compound in-house from single-source ingredients; some source pre-mixed bags from 503A or 503B pharmacies. Diligence should confirm: where the target’s formulations come from; the compounding pharmacy relationships; the storage, handling, and expiration-date tracking; and any incidents involving contamination or adverse reactions. Compounding-related exposure has grown into a real category — the Texas death from IV therapy in a med-spa context prompted enforcement scrutiny nationally.
5. Mobile operation compliance. Mobile and concierge IV businesses face the same CPOM, GFE, and standardized procedures requirements as brick-and-mortar clinics. They also face operational challenges that brick-and-mortar practices do not — safe transport of medications and equipment, temperature control, waste disposal, emergency response for reactions in a client’s home. Diligence on a mobile target should include the operational-safety infrastructure, incident logs, and the professional liability coverage. Some professional liability policies exclude mobile administration or require specific endorsements; standard policies for brick-and-mortar clinics may not cover the target’s operating model.
6. Controlled-substance considerations. Some IV formulations include controlled substances (ketamine for chronic pain and mood indications, testosterone for HRT-adjacent programs, occasionally others). If the target administers any controlled substance, confirm the prescriber’s DEA registration is active, the storage and inventory records comply with 21 C.F.R., the disposal records reconcile, and the CURES reporting is current. Controlled-substance IV therapy also implicates the ketamine clinic analysis (see the practice page on ketamine clinic formation and compliance).
7. Marketing representations. IV marketing that promises specific outcomes — immunity boosting, hangover cure, athletic recovery, chronic fatigue resolution, anti-aging, immune-support — is a false-advertising exposure category under B&P § 17500 and the Unfair Competition Law. The FDA has publicly cautioned against unsupported claims. Diligence should audit the target’s marketing content, testimonial framing, before-and-after imagery, and social media for outcome representations that would not survive scrutiny. Historical marketing exposure travels with the target’s operating history.

Structuring the Compliant IV Acquisition

The general non-licensee acquisition sequence applies. Three IV-specific structuring notes.

Physician-partner considerations. IV-experienced physicians can come from several backgrounds — emergency medicine, family or internal medicine with wellness or functional-medicine interests, integrative medicine, or (for higher-intensity infusion practices) anesthesiology or pain medicine. The physician’s willingness to conduct or supervise GFEs, review and approve standardized procedures, and be immediately available during operations is the substantive negotiation. Ideal candidates are physicians who want an operational role, not just a paper association.

MSA drafting for IV. The MSA between the buyer’s MSO and the physician-partner’s PC follows the general pattern. IV-specific provisions typically address: compounding pharmacy relationships and any 503A/503B sourcing arrangements as MSO-provided services; the standardized procedures and GFE workflow as PC-controlled clinical processes; the mobile-operation safety infrastructure (if applicable) allocated appropriately; and the marketing controls (given the outcome-claim exposure).

Payor and licensure. Most IV clinics are cash-pay or membership-model with limited payor enrollment. The Medicare CHOW analysis under 42 C.F.R. § 489.18 typically does not apply. For clinics that offer superbill support to patients seeking commercial insurance reimbursement, the analysis is more nuanced — the target’s superbill practices should be diligence-reviewed. DEA registration transitions apply where controlled substances are administered.

When to Bring Counsel Into an IV Acquisition

Before the LOI is signed. IV hydration is a category where sellers often have not received California-specific counsel and where the “wellness” framing has, in many cases, resulted in operating structures that do not survive diligence in the form the seller presents. Pre-LOI structuring counsel is where the deal is either built for compliance from the beginning or set up to inherit the seller’s defects.

Bay Legal, PC represents non-licensee buyers of California IV hydration businesses. Call (650) 668-8000 or schedule a consultation at baylegal.com/contact.

Frequently Asked Questions

Can a non-doctor buy an IV hydration business in California?

Yes, through the friendly-PC + MSO structure. A licensed physician acquires the clinical assets (patient records, clinical goodwill, protocols) into a newly formed professional corporation; the buyer’s management entity acquires the non-clinical assets (facility, equipment, trade name, systems) and provides services to the PC under a Management Services Agreement. Direct purchase of the seller’s LLC and continued operation through the LLC is not a compliant path.

Can an RN own or partner in the IV business?

An RN can own an MSO that contracts with a physician-owned PC providing IV services. An RN cannot own the professional corporation that renders the medical services — that ownership is limited to licensed physicians (and, in certain configurations, minority allied-professional shareholders under Cal. Corp. Code § 13401.5). The RN-as-MSO-owner path is the standard structure for nurse entrepreneurs entering California IV practice.

Do mobile IV businesses follow the same rules as brick-and-mortar clinics?

Yes. There is no mobile carve-out from CPOM, the good-faith exam requirement, or standardized procedures. The clinical structure requirements apply equally. Mobile operations add operational-safety, insurance, and emergency-response considerations that brick-and-mortar practices do not face.

What is a “patient-specific order” and why does it matter for IV?

A patient-specific order is a prescription or treatment order written by a licensed prescriber (physician, NP, or PA) for a specific patient after a good-faith exam, specifying the treatment plan (formulation, dose, frequency) for that patient. The 2026 California Medical Board and BRN posture treats standing orders (a single blanket order covering all patients) as insufficient for IV therapy. A compliant target has patient-specific orders documented in each patient chart; a non-compliant target relies on standing orders and RN discretion at the point of administration.

How is IV clinic diligence different from med spa or hyperbaric diligence?

Every California treatment business has the same core CPOM diligence framework. IV adds seven category-specific issues: physician role in prescribing and supervision; GFE workflow specifics; standardized procedures for RN administration; sterile compounding and formulation sourcing; mobile-operation compliance; controlled-substance registration where applicable; and IV-specific marketing exposure. The framework is the same; the checklist items differ.

Talk to a California IV Acquisition Attorney

Bay Legal, PC represents non-licensee buyers of California IV hydration businesses. Whether the target is brick-and-mortar, mobile, membership-model, or a hybrid, we can help you structure the deal for CPOM compliance and identify the IV-specific issues before they become closing problems. Call (650) 668-8000 or schedule a consultation at baylegal.com/contact.